for what it is worth, here is the latest corporate presentation from Suven
http://www.bseindia.com/corporates/ann.aspx?scrip=530239&dur=A&expandable=0
While I am in the group that is waiting for a jackpot (slide 32) with one of the molecules of Suven, I also know for a fact that 502 is a long way from getting there…I also saw decent news analysis of how close Lilly got there, only to be slapped with a failure notice during Phase 3 trials of a similar drug for Alzheimer disease. The failure rate is almost 99% since no one has succeeded in this frustrating journey……………long, long way to go for Suven but as Tim Robbins will say in the movie Shawshank Redemption ” hope is a good thing, maybe the best of things, and no good thing ever dies”
http://www.fiercebiotech.com/story/eli-lilly-offers-evidence-twice-failed-solanezumabs-impact-alzheimers/2015-07-22
PS – invested; views may be biased
| Subscribe To Our Free Newsletter |
